Find a Doctor

Areas of Expertise

Elite

Distinguished

Advanced

Experienced

Gallbladder Cancer
Necrotizing Granuloma

Dr. Christoph Schramm

University Medical Center Hamburg Eppendorf

Bio

Dr. Schramm is a global expert in Sclerosing Cholangitis. He has been an author on 219 peer reviewed articles in the past 15 years. In particular, he has been an author on 71 peer reviewed articles regarding Sclerosing Cholangitis.

Areas of Expertise

Elite

Distinguished

Advanced

Experienced

Gallbladder Cancer
Necrotizing Granuloma

Contact

Latest Advances

Condition: Primary Biliary Cholangitis (PBC)
Journal: Journal of hepatology
Treatment Used: Preventative Ursodeoxycholic Acid (UDCA) after Transplantation
Number of Patients: 780
Published — April 11, 2020

This study tested the safety and efficacy of using UDCA after transplantation to treat patients with PBC.

Condition: Autoimmune Hepatitis (AIH)
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Treatment Used: Liver Transplantation (LT)
Number of Patients: 30970
Published — March 01, 2020

This study analyzed long-term patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT).

Condition: Primary Sclerosing Cholangitis (PSC)
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Treatment Used: Tumor Necrosis Factor (TNF) Antagonists
Number of Patients: 141
Published — February 19, 2020

This study evaluated the effects of tumor necrosis factor (TNF) antagonists (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events) in patients with primary sclerosing cholangitis (chronic disease in which the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked; PSC).

Condition: Autoimmune Hepatitis (AIH)
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Treatment Used: Rapid Response to Treatment
Number of Patients: 740
Published — November 13, 2019

This study assessed he outcomes of patients with vs without rapid response to treatment of autoimmune hepatitis (AIH) in a large international cohort.

Condition: Autoimmune Hepatitis
Journal: United European gastroenterology journal
Treatment Used: Steroid Induction Therapy Followed by Maintenance Therapy with Azathioprine, Second-Line Treatment with Other Immunosuppressants
Number of Patients: 0
Published — November 09, 2019

This article discusses the treatment of autoimmune hepatitis, a rare and chronic liver disease that is characterized by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies.

Condition: Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Treatment Used: Vedolizumab
Number of Patients: 102
Published — May 18, 2019

The study researched the outcomes of Vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases.

Condition: Bloodstream Infection in Patients With Liver Cirrhosis
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Treatment Used: Extended Infusion of ?-Lactams
Number of Patients: 312
Published — January 17, 2019

The study researched the outcomes of extended infusion of ?-Lactams for bloodstream Infection in patients with liver cirrhosis.